Structure-based discovery of anti-influenza virus A compounds among medicines
Authors:
- Moeko MinakuchiMMMoeko Minakuchi
- Atsushi KawaguchiAKAtsushi Kawaguchi
- Kyosuke NagataKNKyosuke Nagata
- Yuji O. KamatariYuji O. Kamatari
- Kazuo KuwataKKKazuo Kuwata
- 1 February 2012
- journal article
- Published by Elsevier in Biochimica et Biophysica Acta (BBA) - General Subjects
- Vol. 1820 (2) , 90-95
Abstract
No abstract availableKeywords
This publication has 27 references indexed in Scilit:
- Neuraminidase-inhibitor resistance testing for pandemic influenza A (H1N1) 2009 in Ontario, CanadaJournal of Clinical Virology, 2011
- High-throughput identification of compounds targeting influenza RNA-dependent RNA polymerase activityProceedings of the National Academy of Sciences, 2010
- Effect of Neuraminidase Inhibitor–Resistant Mutations on Pathogenicity of Clade 2.2 A/Turkey/15/06 (H5N1) Influenza Virus in FerretsPLOS Pathogens, 2010
- T-705 (favipiravir) activity against lethal H5N1 influenza A virusesProceedings of the National Academy of Sciences, 2009
- Identification of a PA-Binding Peptide with Inhibitory Activity against Influenza A and B Virus ReplicationPLOS ONE, 2009
- Emergence and pandemic potential of swine-origin H1N1 influenza virusNature, 2009
- Mesoionic Heterocyclic Compounds as Candidate Messenger RNA Cap Analogue Inhibitors of the Influenza Virus RNA Polymerase Cap-Binding ActivityAntiviral Chemistry and Chemotherapy, 2009
- The structural basis for an essential subunit interaction in influenza virus RNA polymeraseNature, 2008
- Antiviral Resistance in Influenza Viruses — Implications for Management and Pandemic ResponseNew England Journal of Medicine, 2006
- Synthesis and biological evaluation of novel bisheterocycle-containing compounds as potential anti-influenza virus agentsBioorganic & Medicinal Chemistry Letters, 2005